Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shangbin Yang

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
American Journal of Hematology|December 12, 2017
No major differences in outcomes between the initial and relapse episodes in patients with thrombotic thrombocytopenic purpura: The experience from the Ohio State University RegistryCamila Masias, Haiwa Wu, Michael McGookey, et al.
Nanoscale|November 10, 2010
Controllable fabrication of soap-bubble-like structured polyacrylic acid nano-nets via electro-nettingShangbin Yang, Xianfeng Wang, Bin Ding, et al.
Nanoscale|December 15, 2010
Electro-netting: fabrication of two-dimensional nano-nets for highly sensitive trimethylamine sensingXianfeng Wang, Bin Ding, Jianyong Yu, et al.
Neurospine|April 5, 2023
Activating Endogenous Neurogenesis for Spinal Cord Injury Repair: Recent Advances and Future ProspectsHaiyang Yu, Shangbin Yang, Haotao Li, et al.
Frontiers in Oncology|April 3, 2023
Identification of LSM family members as potential chemoresistance predictive and therapeutic biomarkers for gastric cancerQianhui Liu, Qinghai Lian, Yingqiu Song, et al.
Blood|April 4, 2014
Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTPSpero R Cataland, V Michael Holers, Susan Geyer, et al.
British Journal of Haematology|July 22, 2014
Clinical utility of complement biomarkers in the diagnosis and treatment of acute thrombotic microangiopathiesJennifer Yui, V Michael Holers, Shangbin Yang, et al.
British Journal of Haematology|February 18, 2020
Interrelationship between ADAMTS13 activity, von Willebrand factor, and complement activation in remission from immune-mediated trhrombotic thrombocytopenic purpuraHaiwa Wu, Lauren Jay, Shili Lin, et al.
International Journal of Medical Sciences|January 9, 2025
PUF60 Promotes Chemoresistance Through Drug Efflux and Reducing Apoptosis in Gastric CancerQianhui Liu, Yingqiu Song, Jing Su, et al.
Transfusion|June 24, 2014
Diagnostic and prognostic values of ADAMTS13 activity measured during daily plasma exchange therapy in patients with acquired thrombotic thrombocytopenic purpuraNan Wu, Jia Liu, Shangbin Yang, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
American Journal of Hematology|December 12, 2017
No major differences in outcomes between the initial and relapse episodes in patients with thrombotic thrombocytopenic purpura: The experience from the Ohio State University RegistryCamila Masias, Haiwa Wu, Michael McGookey, et al.
Nanoscale|November 10, 2010
Controllable fabrication of soap-bubble-like structured polyacrylic acid nano-nets via electro-nettingShangbin Yang, Xianfeng Wang, Bin Ding, et al.
Nanoscale|December 15, 2010
Electro-netting: fabrication of two-dimensional nano-nets for highly sensitive trimethylamine sensingXianfeng Wang, Bin Ding, Jianyong Yu, et al.
Neurospine|April 5, 2023
Activating Endogenous Neurogenesis for Spinal Cord Injury Repair: Recent Advances and Future ProspectsHaiyang Yu, Shangbin Yang, Haotao Li, et al.
Frontiers in Oncology|April 3, 2023
Identification of LSM family members as potential chemoresistance predictive and therapeutic biomarkers for gastric cancerQianhui Liu, Qinghai Lian, Yingqiu Song, et al.
Blood|April 4, 2014
Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTPSpero R Cataland, V Michael Holers, Susan Geyer, et al.
British Journal of Haematology|July 22, 2014
Clinical utility of complement biomarkers in the diagnosis and treatment of acute thrombotic microangiopathiesJennifer Yui, V Michael Holers, Shangbin Yang, et al.
British Journal of Haematology|February 18, 2020
Interrelationship between ADAMTS13 activity, von Willebrand factor, and complement activation in remission from immune-mediated trhrombotic thrombocytopenic purpuraHaiwa Wu, Lauren Jay, Shili Lin, et al.
International Journal of Medical Sciences|January 9, 2025
PUF60 Promotes Chemoresistance Through Drug Efflux and Reducing Apoptosis in Gastric CancerQianhui Liu, Yingqiu Song, Jing Su, et al.
Transfusion|June 24, 2014
Diagnostic and prognostic values of ADAMTS13 activity measured during daily plasma exchange therapy in patients with acquired thrombotic thrombocytopenic purpuraNan Wu, Jia Liu, Shangbin Yang, et al.
Pageof 4